New study aims to find best pain block for liver cancer surgery recovery
NCT ID NCT07337330
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ultrasound-guided nerve blocks—external oblique intercostal plane block and erector spinae block—for pain relief after liver surgery in cancer patients. Fifty-two adults will receive one of the two blocks, and researchers will measure pain scores and morphine use over 24 hours. The goal is to identify which block offers better pain control and reduces the need for opioids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- nerve block (local anesthetic injection)
- What this could lead to
- If successful, this study could show which nerve block technique is better for controlling pain after liver surgery, potentially improving recovery and reducing opioid use.
- What could go wrong
- This is a small, early-stage study with only 52 participants, so results may not apply to all patients. The blocks may not provide sufficient pain relief for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Institute - Cairo University
Cairo, 11796, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could opioid tolerance dull the power of local anesthetics?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare